Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Cancer Health Center

Font Size

Osteoporosis Drug Approved for Cancer-Related Bone Pain

Xgeva Reduced Fractures, Pain in People With Advanced Cancer
By Katrina Woznicki
WebMD Health News
Reviewed by Laura J. Martin, MD

Nov. 23, 2010 -- The FDA has approved Xgeva (denosumab), an osteoporosis drug reformulated to reduce the risk of bone fractures and bone pain in patients with cancer that has spread throughout the body.

The FDA based its approval on three clinical trials involving more than 5,700 patients with various cancers, including breast and prostate cancer. The trials compared Xgeva with a similar drug, Zometa.

Researchers looked at groups of cancer patients on one of the two medications and measured the time until occurrence of skeletal-related events such as a bone fracture or spinal cord compression due to their cancer or until surgery or radiation was needed to alleviate severe bone pain.

The clinical trial results showed Xgeva was more effective overall than Zometa in preventing skeletal-related events; among men with prostate cancer, the median time to developing a bone fracture or cancer-related bone pain requiring treatment was 21 months among those taking Zometa vs. 17 months for those taking Xgeva.

Likewise, among women with breast cancer, the median time was 26 months for patients taking Zometa, whereas cancer-related bone injuries had not yet occurred among those taking Xgeva during the study period.

Among patients with solid tumors, including patients with non-small-cell lung cancer, kidney cancer, and small-cell lung cancer, the time to developing cancer-related bone injuries or pain was the same between those taking Zometa and those taking Xgeva.

Xgeva has not been approved by the FDA for patients with multiple myeloma or other cancers of the blood.

"Bone metastases represent a major cause of pain and suffering in patients with cancer and can affect a patient's quality of life," said Richard Pazdur, MD, director of the Office of Oncology Drug Products in the FDA's Center for Drug Evaluation and Research. "Xgeva has a different mechanism of action than currently approved drugs aimed at reducing bone complications from cancer."

A Costly Problem

Cancer-related bone injury and pain is common in advanced cancer. According to Amgen, the California-based biotechnology company that manufacturers Xgeva, as many as 75% of patients with advanced lung, prostate, or breast cancer experience cancer spreading to their bones, known as metastases. Amgen reports that the total economic burden of patients with bone metastases in the U.S. is about $12.6 billion annually.

Today on WebMD

Colorectal cancer cells
New! I AM Not Cancer Facebook Group
Lung cancer xray
See it in pictures, plus read the facts.
sauteed cherry tomatoes
Fight cancer one plate at a time.
Ovarian cancer illustration
Real Cancer Perspectives
Jennifer Goodman Linn self-portrait
what is your cancer risk
colorectal cancer treatment advances
breast cancer overview slideshow
prostate cancer overview
lung cancer overview slideshow
ovarian cancer overview slideshow
Actor Michael Douglas